Estimation of marginal structural models under irregular visits and unmeasured confounder: calibrated inverse probability weights

BMC Med Res Methodol. 2023 Jan 7;23(1):4. doi: 10.1186/s12874-022-01831-2.

Abstract

Clinical information collected in electronic health records (EHRs) is becoming an essential source to emulate randomized experiments. Since patients do not interact with the healthcare system at random, the longitudinal information in large observational databases must account for irregular visits. Moreover, we need to also account for subject-specific unmeasured confounders which may act as a common cause for treatment assignment mechanism (e.g. glucose-lowering medications) while also influencing the outcome (e.g. Hemoglobin A1c). We used the calibration of longitudinal weights to improve the finite sample properties and to account for subject-specific unmeasured confounders. A Monte Carlo simulation study is conducted to evaluate the performance of calibrated inverse probability estimators using time-dependent treatment assignment and irregular visits with subject-specific unmeasured confounders. The simulation study showed that the longitudinal weights with calibrated restrictions improved the finite sample bias when compared to the stabilized weights. The application of the calibrated weights is demonstrated using the exposure of glucose lowering medications and the longitudinal outcome of Hemoglobin A1c. Our results support the effectiveness of glucose lowering medications in reducing Hemoglobin A1c among type II diabetes patients with elevated glycemic index ([Formula: see text]) using stabilized and calibrated weights.

Keywords: Calibrated weights; Constrained optimization; Electronic health records; Longitudinal data analysis; Marginal structural models; Primary care.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Computer Simulation
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucose / therapeutic use
  • Glycated Hemoglobin
  • Humans
  • Models, Statistical*
  • Models, Structural
  • Probability

Substances

  • Glycated Hemoglobin
  • Glucose